Elsevier Science, Inc.

SHERPA: Unknown

People

  1. Scher
    Scher
  2. Motzer
    Motzer
  3. Bajorin
    Bajorin
  4. Morris
    Morris
  5. Reuter
    Reuter
  6. Rosenberg
    Rosenberg
  7. Sheinfeld
    Sheinfeld
  8. Feldman
    Feldman
  9. Russo
    Russo
  10. Solit
    Solit

Groups

  1. Department of Medicine (389)
  2. Genitourinary Oncology Service (389)
  3. Solid Tumor Oncology Division (389)
  4. Surgery (113)
  5. Urology (109)
  6. Department of Pathology and Laboratory Medicine (65)
  7. Survivorship Research (59)
  8. GSK Faculty (58)
  9. Epidemiology and Biostatistics (51)
  10. Human Oncology and Pathogenesis Program (41)
Search Within
  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (318)
  2. Meeting Abstract (26)
  3. Review (14)
  4. Correspondence (12)
  5. Editorial (10)
  6. Conference Paper (4)
  7. Research Letter (3)
  8. Guidelines (2)
Groups
  1. Department of Medicine (389)
  2. Genitourinary Oncology Service (389)
  3. Solid Tumor Oncology Division (389)
  4. Surgery (113)
  5. Urology (109)
  6. Department of Pathology and Laboratory Medicine (65)

More Groups

People
  1. Howard Scher (119)
  2. Robert Motzer (111)
  3. Dean Bajorin (58)
  4. Michael Morris (39)
  5. Jonathan Rosenberg (35)
  6. Victor Reuter (35)

More People

Years
  1. 2025 (8)
  2. 2024 (21)
  3. 2023 (28)
  4. 2022 (18)
  5. 2021 (20)
  6. 2020 (23)

More Years

Publications
  1. European Urology (118)
  2. Journal of Urology (101)
  3. Lancet Oncology (52)
  4. Urology (52)
  5. Lancet (14)
  6. Value in Health (12)

More Publications

Results (389)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Low incidence of corticosteroid-associated adverse events on long-term exposure to low-dose prednisone given with abiraterone acetate to patients with metastatic castration-resistant prostate cancer
    Journal Article

    Fizazi, K.; Chi, K. N.; de Bono, J. S.; Gomella, L. G.; Miller, K.; Rathkopf, D. E.; Ryan, C. J.; Scher, H. I.; Shore, N. D.; De Porre, P.; more...
    European Urology (2016)

    Fulltext@MSK | Save
  • Pelvic lymph node dissection in patients treated for testis cancer: The Memorial Sloan Kettering Cancer Center experience
    Journal Article

    Alanee, S. R.; Carver, B. S.; Feldman, D. R.; Motzer, R. J.; Bosl, G. J.; Sheinfeld, J.
    Urology (2016)

    Fulltext@MSK | Save
  • Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): Final results from a randomised, open-label, phase 3 trial
    Journal Article

    Choueiri, T. K.; Escudier, B.; Powles, T.; Tannir, N. M.; Mainwaring, P. N.; Rini, B. I.; Hammers, H. J.; Donskov, F.; Roth, B. J.; Peltola, K.; more...
    Lancet Oncology (2016)

    Fulltext@MSK | Save
  • Genomic biomarkers for the prediction of stage and prognosis of upper tract urothelial carcinoma
    Journal Article

    Bagrodia, A.; Cha, E. K.; Sfakianos, J. P.; Zabor, E. C.; Bochner, B. H.; Al-Ahmadie, H. A.; Solit, D. B.; Coleman, J. A.
    Journal of Urology (2016)

    Fulltext@MSK | Save
  • Prior endocrine therapy impact on abiraterone acetate clinical efficacy in metastatic castration-resistant prostate cancer: Post-hoc analysis of randomised phase 3 studies
    Journal Article

    Bellmunt, J.; Kheoh, T.; Yu, M. K.; Smith, M. R.; Small, E. J.; Mulders, P. F. A.; Fizazi, K.; Rathkopf, D. E.; Saad, F.; Scher, H. I.; more...
    European Urology (2016)

    Fulltext@MSK | Save
  • Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: A single-arm, multicentre, phase 2 trial
    Journal Article

    Rosenberg, J. E.; Hoffman-Censits, J.; Powles, T.; van der Heijden, M. S.; Balar, A. V.; Necchi, A.; Dawson, N.; O'Donnell, P. H.; Balmanoukian, A.; Loriot, Y.; more...
    Lancet (2016)

    Fulltext@MSK | Save
  • Defining new standards of care for men with prostate cancer
    Journal Article

    Scher, H. I.
    Lancet (2016)

    Fulltext@MSK | Save
  • Independent assessment of lenvatinib plus everolimus in patients with metastatic renal cell carcinoma
    Journal Article

    Motzer, R. J.; Hutson, T. E.; Ren, M.; Dutcus, C.; Larkin, J.
    Lancet Oncology (2016)

    Fulltext@MSK | Save
  • Improved 5-factor prognostic classification of patients receiving salvage systemic therapy for advanced urothelial carcinoma
    Journal Article

    Sonpavde, G.; Pond, G. R.; Rosenberg, J. E.; Bajorin, D. F.; Choueiri, T. K.; Necchi, A.; di Lorenzo, G.; Bellmunt, J.
    Journal of Urology (2016)

    Fulltext@MSK | Save
  • Risk of vascular toxicity with platinum based chemotherapy in elderly patients with bladder cancer
    Journal Article

    Gupta, A.; Long, J. B.; Chen, J.; Gross, C. P.; Feldman, D. R.; Steingart, R. M.
    Journal of Urology (2016)

    Fulltext@MSK | Save